Eidai Co.,Ltd.
Eidai Co.,Ltd. (7822.T) Financial Performance & Income Statement Overview
Review Eidai Co.,Ltd. (7822.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Eidai Co.,Ltd. (7822.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Eidai Co.,Ltd. 7822.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $18.01B | $19.18B | $16.98B | $17.03B |
| Cost of Revenue | $14.10B | $15.09B | $13.63B | $13.61B |
| Gross Profit | $3.91B | $4.09B | $3.34B | $3.42B |
| Gross Profit Ratio | $0.22 | $0.21 | $0.20 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.79B | $3.84B | $3.71B | $3.72B |
| Operating Expenses | $3.79B | $3.84B | $3.71B | $3.72B |
| Total Costs & Expenses | $17.89B | $18.93B | $17.34B | $17.33B |
| Interest Income | $4.00M | $0.00 | $0.00 | $2.00M |
| Interest Expense | $95.00M | $0.00 | $0.00 | $88.00M |
| Depreciation & Amortization | $879.00M | $861.00M | $844.00M | $779.75M |
| EBITDA | $1.02B | $1.03B | $464.00M | $478.75M |
| EBITDA Ratio | $0.06 | $0.05 | $0.03 | $0.03 |
| Operating Income | $122.00M | $251.00M | -$365.00M | -$301.00M |
| Operating Income Ratio | $0.007 | $0.01 | -$0.02 | -$0.02 |
| Other Income/Expenses (Net) | -$79.00M | -$28.00M | -$65.00M | $74.00M |
| Income Before Tax | $43.00M | $223.00M | -$430.00M | -$227.00M |
| Income Before Tax Ratio | $0.002 | $0.01 | -$0.03 | -$0.01 |
| Income Tax Expense | -$10.00M | $297.00M | $84.00M | $91.00M |
| Net Income | $241.00M | $157.00M | -$286.00M | -$140.00M |
| Net Income Ratio | $0.01 | $0.008 | -$0.02 | -$0.008 |
| EPS | $5.45 | $3.53 | -$6.47 | -$3.17 |
| Diluted EPS | $5.45 | $3.53 | -$6.47 | -$3.17 |
| Weighted Avg Shares Outstanding | $44.20M | $44.20M | $44.20M | $44.20M |
| Weighted Avg Shares Outstanding (Diluted) | $44.20M | $44.20M | $44.20M | $44.20M |
Over the past four quarters, Eidai Co.,Ltd. demonstrated steady revenue growth, increasing from $17.03B in Q1 2024 to $18.01B in Q4 2024. Operating income reached $122.00M in Q4 2024, maintaining a consistent 1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.02B, reflecting operational efficiency. Net income rose to $241.00M, with EPS at $5.45. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan